|
|
||||||||||
|
J Am Coll Cardiol, 2004; 44:1578-1583, doi:10.1016/j.jacc.2004.06.073 © 2004 by the American College of Cardiology Foundation |


* Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain
Emergency Unit
Epidemiology Department, Cardiovascular Research Laboratory, Fundación Jiménez Díaz, Madrid, Spain
Manuscript received December 16, 2003; revised manuscript received April 21, 2004, accepted June 16, 2004.
* Reprint requests and correspondence: Dr. Luis A. Rico, Cardiovascular Research Laboratory, Fundación Jiménez Díaz, Avda. Reyes Catolicos, 2, Madrid 28040, Spain (Email: rico{at}fjd.es).
OBJECTIVES: The aim of this study was to analyze modifications in the plasma protein map during an acute coronary syndrome (ACS) using proteomics.
BACKGROUND: Proteomics is a new technology that allows the detection and identification of several proteins at a given time in a sample.
METHODS: Plasma from 19 patients, 11 with acute myocardial infarction (AMI) and 8 with unstable angina (UA), was investigated. The control group included nine age-matched volunteers.
RESULTS: In two-dimensional electrophoresis using a pH range of 4 to 7, constant differences were found in at least four different areas within the plasma protein map. In area 1, we identified the presence of seven alpha1-antitrypsin (AAT) isoforms in plasma from control subjects. alpha1-antitrypsin isoform 1 was undetectable in plasma from UA and AMI patients. The AAT isoforms 5, 6, and 7 were reduced in plasma from AMI patients when compared with UA patients. Three fibrinogen gamma chain isoforms were identified in area 2. Fibrinogen gamma chain isoforms 1 and 2 were increased in AMI patients with respect to UA patients. Five apolipoprotein A-I isoforms were identified in area 3. All of them were reduced in plasma from AMI patients with respect to UA patients. In area 4, the
-immunoglobulin heavy chains were detected and were found increased in plasma from ACS patients.
CONCLUSIONS: Plasma proteomic analysis makes it possible to develop a map of the protein isoforms that are expressed in plasma during an ACS.
| ||||||||||
This article has been cited by other articles:
![]() |
P. Matt, T. Carrel, M. White, I. Lefkovits, and J. Van Eyk Proteomics in cardiovascular surgery J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 210 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arab, A. O. Gramolini, P. Ping, T. Kislinger, B. Stanley, J. van Eyk, M. Ouzounian, D. H. MacLennan, A. Emili, and P. P. Liu Cardiovascular Proteomics: Tools to Develop Novel Biomarkers and Potential Applications J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1733 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Blanco-Colio, J. L. Martin-Ventura, F. Vivanco, J.-B. Michel, O. Meilhac, and J. Egido Biology of atherosclerotic plaques: What we are learning from proteomic analysis Cardiovasc Res, October 1, 2006; 72(1): 18 - 29. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |